IgM is the first antibody to appear in the acute infection stage caused by pathogens such as SARS-CoV-2, and can normally be detected 3 days after the onset of symptoms, IgG is produced in the middle or later stage of the infection but provides long-term protection. In the latest Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7), the SARS-CoV-2 IgG/IgM test is recommended as an aid in the diagnosis of the COVID-19.
● 7 mins rapid test
● Various specimen types (whole blood/serum/plasma)
● Simultaneous detection of IgG and IgM
● Important complement to PCR detection in COVID-19 diagnosis
Cat.No | Description | Package size |
CG122001 CG122025 | SARS-CoV-2 IgG/IgM Antibody Kit (Colloidal Gold) | 1/25 T |
CG122001 CG122025 | SARS-CoV-2 IgG/IgM Antibody Kit (Immunofluorescence) | 1/25 T |
Colloidal gold | Principle | Immunofluorescence |
qualitative | Result assessment | quantitative |
whole blood/ serum/ plasma | Sample type | whole blood/ serum/ plasma |
No | Instrument requirement | Yes |
Yes | Buffer requirement | No |
Home Products About Goldsite Support Solutions Download News Contact Us Privacy Policy